Jim Cramer breaks down the Trump administration's consideration to stop U.S. investing in Chinese businesses, recommends foreign pharmaceutical companies, reviews Conagra's earnings report and interview GoodRx CEO Doug Hirsch.
from Top News & Analysis https://ift.tt/2nfRylz
No comments:
Post a Comment